FDA Inspection 1136832 — Peter R. Carroll, M.D., M.P.H.
The FDA completed an inspection of Peter R. Carroll, M.D., M.P.H. on February 24, 2021 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 24, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Francisco, CA (United States)
Additional Details
Clinical Investigator (CI)